Research Article

Effect of Surface-Modified Paclitaxel Nanowires on U937 Cells In Vitro: A Novel Drug Delivery Vehicle

Figure 3

Vials containing paclitaxel in 20% H3PO4/0.4% SDS. (a) 580  𝜇 g of paclitaxel microcrystals (FT). (b) 580  𝜇 g of paclitaxel in the form of SM-PNs with 200 nm diameter and 50  𝜇 m long. (c) 580  𝜇 g of paclitaxel in the form of SM-PNs with 35 nm diameter and 50  𝜇 m long. For comparison, note the visibility of the bottom rim of the vial. Each vial contains around 1 mL of 20% H3PO4/0.4% SDS.
328520.fig.003